Effective disease‐specific therapies included dopaminergic agents for neurotransmitters disorders, ketogenic diet for glucose transporter deficiency, and deep brain stimulation for SGCE‐, KMT2B‐, and GNAO1‐related hyperkinesia. Here, KMT2B is linked to Hyperkinetic movements.